期刊文献+

性激素和精神分裂症精神病理的相关性研究 被引量:9

Study of correlation between sex hormone and psychopathology in schizophrenic patients
下载PDF
导出
摘要 目的探讨性激素和精神分裂症精神病理性别差异的相关性。方法将60例女性、20例男性精神分裂症患者,于治疗前进行阳性和阴性综合征量表(PANSS)评定以及雌二醇(E2)、睾酮(T)、催乳素(PRL)、促卵泡激素(FSH)、黄体生成素(LH)的检测并与20名(男女各10名)正常人对照。结果男性患者E2、T水平均低于对照组(P<0.01),女性患者E2水平低于对照组(P<0.01)。女性患者PANSS阳性症状评分高于男性患者(P=0.008),阴性症状评分低于男性患者(P=0.001)。女性患者的E2水平与阴性症状评分呈负相关(P=0.020),而男性患者的E2及T水平均与阴性症状评分呈负相关(P=0.010,P=0.049)。结论精神分裂症患者在精神病理上存在性别差异,而这种差异与雌激素、睾酮存在相关性。 Objective To explore the correlation between serum level of sex hormones and gender difference in psychopathology in schizophrenia.Methods The serum level of estradiol (E2),testosterone (T),prolactin (PRL),follicle-stimulating hormone (FSH)and luteinizing hormone (LH)were measured in 80 treatment-nave schizophrenic patients (study group,60 females and 20 males)and 20 healthy controls (control group,10 females and 10 males).All subjects in study group were assessed with Positive and Negative Syndrome Scale (PANSS)before treatment.Results Serum levels of E2 and T in male schizophrenic patients were significantly lower than those in control group (P 〈0.01),and serum level of E2 in female patients was significantly lower than that in control group (P 〈0.01).Factor score of positive symptoms (P)of PANSS in female patients was significantly higher than that in male patients (P =0.008),while factor score of negative symptoms in female patients was significantly lower than that in male patients (P =0.001 ).Serum level of E2 in female patients was significantly negatively correlated with factor score of N (P =0.020).However,serum levels of E2 and T in male patients were significantly negatively correlated with factor score of N (P =0.010,0.049 respectively).Conclusion Gender difference exists in the psychopathology of schizophrenia and it may be related with estradiol and testosterone.
出处 《精神医学杂志》 2015年第1期37-39,共3页 Journal of Psychiatry
基金 湖南省常德市科技局(编号:常企财指[2013]50)
关键词 精神分裂症 精神病理 性激素 Schizophrenia Psychopathology Sex hormones
  • 相关文献

参考文献4

二级参考文献38

  • 1翟书涛.抗精神病药与妇女精神分裂症[J].临床精神医学杂志,2006,16(1):52-54. 被引量:5
  • 2闻芳.抗精神病药物应用中的性别差异[J].国际精神病学杂志,2006,33(3):183-186. 被引量:10
  • 3陈兴时,张明岛,楼翡璎,王红星,王继军,郭旗,刘丽,高存友,刘萍,刘效巍,段慧君,郭凤莲,梁建华,陈冲,陈欣伟.P300与首发精神分裂症患者临床症状的关系[J].中华物理医学与康复杂志,2006,28(8):545-548. 被引量:19
  • 4龚耀先,主编.修订韦氏记忆量表手册.第五版.长沙:湖南医科大学,2003.1-50.
  • 5Taherianfard M, Shariaty M. Evaluation of serum steroid hormones in schizophrenic patients [ J ]. Indian J Med Sci, 200d,58 ( ! ) : 3 - 9.
  • 6Saletu B,Anderer P, Di Padova C, et al. Electrophysiological neuroimaging of the central effects of S-adenosy-L-methionine by mapping of electroencephalograms and event-related potentials and lowresolution brain electromagnetic tomography [ J ], Am J Clin Nutr, 2002,76 (5) : 1162s - 1171 s.
  • 7Castle D, Sham P, Murray R. Differences in distribution of age of onset in males and females with schizophrenia [ J ]. Schizophrenia Res, 1998,33(3) :179 - 183.
  • 8Hafner H, Riecher-Rossler A, An Der Heiden W, et al. Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia [ J ]. Psychol Med, 1993,23 (4) : 925 - 940.
  • 9Hoff AL, Kremen WS, Wieneke MH, et al. Association of estrogen levels with neuropsychological performance in woman with schizophrenia[ J]. Am J Psychiatry,2001,158(7) :1134 - 1139.
  • 10Lee D, Wang L, Dong P, et al. Progesterone modulation of D5 receptor expression in hypothalamic ANP neurons, the role of estrogen [J]. Mol Psychiatry J an,2001,6( 1 ) :112 - 117.

共引文献18

同被引文献97

  • 1郭丽阳,郭晓娟,杨睿,亢万虎,高成阁,杨小波.精神分裂症患者不典型抗精神病药治疗前后甲状腺激素的变化[J].西安交通大学学报(医学版),2012,33(2):146-148. 被引量:27
  • 2郭春梅,司天梅,舒良.精神分裂症的性别差异[J].国际精神病学杂志,2006,33(4):199-202. 被引量:15
  • 3张东卫,甘景梨.性激素与精神分裂症的相关性研究进展[J].临床心身疾病杂志,2007,13(2):186-189. 被引量:7
  • 4鲁丽娅,高镇松,李宏伟,李振宇.缺陷型与非缺陷型精神分裂症患者血清催乳素水平比较研究[J].临床心身疾病杂志,2007,13(4):297-298. 被引量:1
  • 5侯林,徐会茹,王晨阳,黄祝,蒋超,黄宇峰,崔英霞,戈一峰,恽时锋,姚兵.恐惧应激对雄性大鼠生殖激素的影响[J].医学研究生学报,2007,20(9):920-922. 被引量:7
  • 6Mizuno Y,Bies RR,Remington G,et al. Dopamine D2 receptor occupancy with risperidone or olanzapine during maintenance treatment of schizophrenia: A cross-sectional study [ J ]. Prog Neuropsychopharmacol Biol Psychiatry, 2012,37 ( 1 ) : 182 - 187.
  • 7Okita K, Kanahara N, Nishimura M,et al. Second-generation antipsychotics and bone turnover in schizophrenia [ J 3. Schizophr Res,2014, 157( 1 - 3) : 137 - 141.
  • 8Wampers M, Hanssens L, van Winkel R, et al. Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: Results from a 3-month prospective open- label study E J ]. European neuropsychopharmacology, 2012, 22(1) :17 -26.
  • 9Baptism T,Lacruz A,Hernandez L. Glucose tolerance and serum insulin levels in an animal model of obesity induced by the antipsychotic drug, sulpride [ J ]. Pharmacology &Toxicology, 1998,83 (2) :57 - 61.
  • 10Tsai EC, Matsumoto AM, Fujimoto WY, et al. Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat[J]. Diabetes Care,2004,27(4) : 861 -868.

引证文献9

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部